AREDS2 Formula
Specifically for Macular Degeneration
0 up • 0 down
Why it works for Macular Degeneration:
It slows progression (it doesn’t cure or prevent AMD). The original AREDS trial showed that a specific high-dose antioxidant + zinc formula reduced the risk of progression to advanced AMD by ~25% over 5 years in people at higher risk (intermediate AMD in one/both eyes or advanced AMD in one eye). National Eye Institute
AREDS2 refined the formula to be safer and at least as effective. AREDS2 replaced beta-carotene with lutein (10 mg) + zeaxanthin (2 mg) and confirmed benefit for the same risk groups; omega-3s did not add benefit. JAMA Network
Who actually benefits: People with intermediate AMD or advanced AMD in one eye; there’s no proven benefit for early AMD or for people without AMD. National Eye Institute
Why beta-carotene was removed: In smokers/former smokers, beta-carotene increased lung-cancer risk; lutein/zeaxanthin provide the retinal carotenoids without that signal. National Eye Institute
Long-term follow-up: At ~10 years, AREDS2 follow-on data showed lower progression to late AMD with lutein/zeaxanthin and higher lung-cancer incidence with beta-carotene in former smokers, reinforcing the AREDS2 switch. JAMA Network
How to use for Macular Degeneration:
Use the AREDS2 formulation (not the older AREDS with beta-carotene). The NEI lists the target daily amounts used in trials:
Vitamin C 500 mg, Vitamin E 400 IU, Zinc 80 mg (as zinc oxide), Copper 2 mg (as cupric oxide), Lutein 10 mg, Zeaxanthin 2 mg. National Eye Institute
Who should take it: Only if your eye-care professional has diagnosed intermediate AMD (one or both eyes) or late AMD in one eye. It will not help early/no AMD. National Eye Institute
Dose & schedule: Commercial AREDS2 products typically divide the above totals into two doses daily with food (check your label; brands vary slightly). Example labels instruct one softgel in the morning and one in the evening to reach the daily totals. bausch.com.sg
Multivitamin? AREDS2 does not replace a multivitamin; it’s okay to use both if your clinician agrees. National Eye Institute
What it’s not: AREDS2 doesn’t treat wet AMD (anti-VEGF injections do) and won’t prevent AMD from starting; it slows progression in the right group. National Eye Institute
Scientific Evidence for Macular Degeneration:
AREDS (2001) — Randomized, placebo-controlled trial; the antioxidant + zinc combo reduced progression to advanced AMD by ~25% in higher-risk participants. (AREDS Report No. 8; summarized by AAO/NEI.) AAO
AREDS2 (JAMA, 2013) — 4,203 participants; lutein/zeaxanthin safely replaced beta-carotene; omega-3s offered no added benefit; variations in zinc dose didn’t materially change outcomes. JAMA Network
AREDS2 10-year follow-up (JAMA Ophthalmology, 2022) — Lower late-AMD progression with lutein/zeaxanthin and increased lung-cancer risk with beta-carotene among former smokers; supports continued AREDS2 use (without beta-carotene). JAMA Network
Cochrane Review (2023 update) — High-quality synthesis: AREDS-type supplements slow AMD progression in people with AMD; evidence does not support prevention in those without AMD. Cochrane
NEI trial hub — Overview pages for AREDS/AREDS2 with patient-facing summaries and ingredient tables. National Eye Institute
Specific Warnings for Macular Degeneration:
Smokers and former smokers: Avoid beta-carotene–containing formulas due to increased lung-cancer risk; choose AREDS2 (with lutein/zeaxanthin, no beta-carotene). National Eye Institute
Anticoagulants / bleeding risk: Vitamin E (400 IU/day) can potentiate bleeding (e.g., with warfarin); discuss AREDS2 with your clinician and consider products with reduced/no vitamin E if advised. Office of Dietary Supplements
Kidney-stone risk / CKD: High-dose vitamin C has been linked (in some studies) to increased oxalate and kidney-stone risk, particularly in men and those with stone history—use AREDS2 with medical guidance if you have kidney disease or prior stones. Office of Dietary Supplements
High zinc dose issues: AREDS used 80 mg/day zinc; very high chronic zinc can cause GI upset, interfere with copper/iron, and has been linked in some data to genitourinary adverse events—that’s why formulas include 2 mg copper; talk to your doctor if you experience side effects or if you’re considering a lower-zinc AREDS2 product. National Eye Institute
General supplement cautions:
- Not for pregnancy/breastfeeding unless specifically advised.
- Drug–nutrient interactions are possible (e.g., vitamin E with anticoagulants; zinc with certain antibiotics).
- Stick to the AREDS2 amounts—more is not better. Consult your ophthalmologist/GP before starting. Office of Dietary Supplements
General Information (All Ailments)
What It Is
The AREDS2 Formula is a specialized nutritional supplement developed based on findings from the Age-Related Eye Disease Study 2 (AREDS2), a large clinical trial sponsored by the National Eye Institute (NEI).
It’s designed to help reduce the risk of progression of age-related macular degeneration (AMD) — a leading cause of vision loss in older adults.
The AREDS2 supplement contains a precise blend of vitamins and minerals shown to protect the retina, particularly the macula, from oxidative stress and inflammation.
Typical AREDS2 formulation:
- Vitamin C – 500 mg
- Vitamin E – 400 IU
- Zinc (as zinc oxide) – 80 mg
- Copper (as cupric oxide) – 2 mg
- Lutein – 10 mg
- Zeaxanthin – 2 mg
Note: Beta-carotene (used in the original AREDS formula) was removed in AREDS2 due to an increased lung cancer risk in smokers and replaced with lutein and zeaxanthin.
How It Works
The AREDS2 formula works primarily through antioxidant and anti-inflammatory mechanisms that protect the macula — the central portion of the retina responsible for detailed vision.
- Antioxidant Protection: Vitamins C and E, along with zinc, help neutralize free radicals that can damage retinal cells due to oxidative stress — a key factor in AMD progression.
- Macular Pigment Support: Lutein and zeaxanthin are carotenoids that accumulate in the macula and form the macular pigment. This pigment filters harmful blue light and protects photoreceptor cells from oxidative damage.
- Structural and Functional Retinal Support: Zinc plays a crucial role in retinal metabolism and supports the function of vitamin A in visual processing. Copper is included to prevent copper deficiency anemia caused by high zinc intake.
Together, these nutrients slow the progression from intermediate to advanced AMD, helping preserve central vision.
Why It’s Important
- Clinically Proven Efficacy: The AREDS2 study demonstrated that this combination of nutrients can lower the risk of developing advanced AMD by about 25% in individuals with intermediate or advanced disease in one eye.
- Protection Against Vision Loss: AMD can severely impact central vision, making reading, driving, and recognizing faces difficult. AREDS2 helps delay this decline.
- Evidence-Based Formulation: Unlike general multivitamins, AREDS2 is specifically tailored to the biological mechanisms of macular degeneration, based on decades of research.
- Safer Than the Original AREDS Formula: The replacement of beta-carotene with lutein and zeaxanthin makes it safer for smokers and ex-smokers, who faced elevated lung cancer risk from beta-carotene.
Considerations
Intended Use:
- AREDS2 is not a cure for AMD but a supportive therapy to slow its progression.
- It’s recommended primarily for individuals with intermediate AMD or advanced AMD in one eye, not for those with early AMD or no disease.
Safety and Tolerability:
- Generally safe when taken as directed, but high-dose zinc may cause gastrointestinal discomfort in some individuals.
- Excessive vitamin E or C intake can interact with certain medications (e.g., blood thinners).
Medical Supervision:
- Always consult an ophthalmologist or healthcare provider before starting AREDS2, especially if you have other health conditions (like kidney disease) or are already on supplements.
Lifestyle Synergy:
- The supplement is most effective when combined with lifestyle measures such as:
- Quitting smoking
- Eating a diet rich in leafy greens and omega-3 fatty acids
- Managing cardiovascular risk factors
Helps with these conditions
AREDS2 Formula is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Macular Degeneration
It slows progression (it doesn’t cure or prevent AMD). The original AREDS trial showed that a specific high-dose antioxidant + zinc formula reduced th...
Community Discussion
Share results, tips, and questions about AREDS2 Formula.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Macular Degeneration
Talk specifically about using AREDS2 Formula for Macular Degeneration.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.